Literature DB >> 17707165

A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil.

Kevin W Waddell1, Malcolm J Avison, James M Joers, John C Gore.   

Abstract

gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in human brain and has been implicated in several neuropsychiatric disorders. In vivo human brain GABA concentrations are near the detection limit for magnetic resonance spectroscopy ( approximately 1 mM), and because of overlap with more abundant compounds, spectral editing is generally necessary to detect GABA. In previous reports, GABA spectra edited by J-difference spectroscopy vary considerably in appearance. We have evaluated the factors that affect GABA spectra and the conditions necessary for robust acquisition of J-difference spectra from arbitrary brain regions. In particular, we demonstrate that variations in spectral quality can be explained in part by the incoherent addition of transients that results from shot to shot frequency and phase variations. An automated time-domain spectral alignment strategy that enables reproducible acquisition of high-quality GABA spectra at 3 T with a standard 30-cm T/R volume coil is presented. Representative GABA spectra from human frontal lobe, an area where susceptibility-induced frequency and phase variations are especially troublesome, that demonstrate the robustness of the acquisition and data handling strategy used in this study are presented.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707165      PMCID: PMC2131736          DOI: 10.1016/j.mri.2006.11.026

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  21 in total

1.  Proton NMR chemical shifts and coupling constants for brain metabolites.

Authors:  V Govindaraju; K Young; A A Maudsley
Journal:  NMR Biomed       Date:  2000-05       Impact factor: 4.044

2.  In vivo GABA editing using a novel doubly selective multiple quantum filter.

Authors:  Jun Shen; Douglas L Rothman; Peter Brown
Journal:  Magn Reson Med       Date:  2002-03       Impact factor: 4.668

3.  Phase coherent averaging in magnetic resonance spectroscopy using interleaved navigator scans: compensation of motion artifacts and magnetic field instabilities.

Authors:  Thorsten Thiel; Michael Czisch; Gregor K Elbel; Juergen Hennig
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

Review 4.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.

Authors:  J H Krystal; G Sanacora; H Blumberg; A Anand; D S Charney; G Marek; C N Epperson; A Goddard; G F Mason
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 5.  Impairment of GABAergic transmission in depression: new insights from neuroimaging studies.

Authors:  G Sanacora; G F Mason; J H Krystal
Journal:  Crit Rev Neurobiol       Date:  2000

6.  Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy.

Authors:  C Neill Epperson; Stephanie O'Malley; Kathryn A Czarkowski; Ralitza Gueorguieva; Peter Jatlow; Gerard Sanacora; Douglas L Rothman; John H Krystal; Graeme F Mason
Journal:  Biol Psychiatry       Date:  2005-01-01       Impact factor: 13.382

7.  Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla.

Authors:  Melissa Terpstra; Kamil Ugurbil; Rolf Gruetter
Journal:  Magn Reson Med       Date:  2002-05       Impact factor: 4.668

8.  Single-shot two-echo technique for simultaneous measurement of GABA and creatine in the human brain in vivo.

Authors:  In-Young Choi; Sang-Pil Lee; Hellmut Merkle; Jun Shen
Journal:  Magn Reson Med       Date:  2004-06       Impact factor: 4.668

9.  Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.

Authors:  Gerard Sanacora; Ralitza Gueorguieva; C Neill Epperson; Yu-Te Wu; Michael Appel; Douglas L Rothman; John H Krystal; Graeme F Mason
Journal:  Arch Gen Psychiatry       Date:  2004-07

10.  Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra.

Authors:  Melissa Terpstra; Pierre-Gilles Henry; Rolf Gruetter
Journal:  Magn Reson Med       Date:  2003-07       Impact factor: 4.668

View more
  64 in total

Review 1.  GABA-based evaluation of neurologic conditions: MR spectroscopy.

Authors:  L M Levy; A J Degnan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

Review 2.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

3.  Big GABA: Edited MR spectroscopy at 24 research sites.

Authors:  Mark Mikkelsen; Peter B Barker; Pallab K Bhattacharyya; Maiken K Brix; Pieter F Buur; Kim M Cecil; Kimberly L Chan; David Y-T Chen; Alexander R Craven; Koen Cuypers; Michael Dacko; Niall W Duncan; Ulrike Dydak; David A Edmondson; Gabriele Ende; Lars Ersland; Fei Gao; Ian Greenhouse; Ashley D Harris; Naying He; Stefanie Heba; Nigel Hoggard; Tun-Wei Hsu; Jacobus F A Jansen; Alayar Kangarlu; Thomas Lange; R Marc Lebel; Yan Li; Chien-Yuan E Lin; Jy-Kang Liou; Jiing-Feng Lirng; Feng Liu; Ruoyun Ma; Celine Maes; Marta Moreno-Ortega; Scott O Murray; Sean Noah; Ralph Noeske; Michael D Noseworthy; Georg Oeltzschner; James J Prisciandaro; Nicolaas A J Puts; Timothy P L Roberts; Markus Sack; Napapon Sailasuta; Muhammad G Saleh; Michael-Paul Schallmo; Nicholas Simard; Stephan P Swinnen; Martin Tegenthoff; Peter Truong; Guangbin Wang; Iain D Wilkinson; Hans-Jörg Wittsack; Hongmin Xu; Fuhua Yan; Chencheng Zhang; Vadim Zipunnikov; Helge J Zöllner; Richard A E Edden
Journal:  Neuroimage       Date:  2017-07-14       Impact factor: 6.556

4.  Chronic cocaine exposure induces putamen glutamate and glutamine metabolite abnormalities in squirrel monkeys.

Authors:  Xiaoxu Liu; J Eric Jensen; Timothy E Gillis; Chun S Zuo; Andrew P Prescot; Melanie Brimson; Kenroy Cayetano; Perry F Renshaw; Marc J Kaufman
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

5.  Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity.

Authors:  Frederic Boy; C John Evans; Richard A E Edden; Andrew D Lawrence; Krish D Singh; Masud Husain; Petroc Sumner
Journal:  Biol Psychiatry       Date:  2011-07-14       Impact factor: 13.382

6.  In vivo neurochemistry of primary focal hand dystonia: a magnetic resonance spectroscopic neurometabolite profiling study at 3T.

Authors:  Priyantha Herath; Cecile Gallea; Jan Willem van der Veen; Silvina G Horovitz; Mark Hallett
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

7.  Frequency and phase correction for multiplexed edited MRS of GABA and glutathione.

Authors:  Mark Mikkelsen; Muhammad G Saleh; Jamie Near; Kimberly L Chan; Tao Gong; Ashley D Harris; Georg Oeltzschner; Nicolaas A J Puts; Kim M Cecil; Iain D Wilkinson; Richard A E Edden
Journal:  Magn Reson Med       Date:  2017-12-07       Impact factor: 4.668

8.  Prospective frequency correction using outer volume suppression-localized navigator for MR spectroscopy and spectroscopic imaging.

Authors:  Chu-Yu Lee; In-Young Choi; Phil Lee
Journal:  Magn Reson Med       Date:  2018-05-13       Impact factor: 4.668

9.  Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders.

Authors:  David M Cochran; Elif M Sikoglu; Steven M Hodge; Richard A E Edden; Ann Foley; David N Kennedy; Constance M Moore; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

Review 10.  Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA.

Authors:  Paul G Mullins; David J McGonigle; Ruth L O'Gorman; Nicolaas A J Puts; Rishma Vidyasagar; C John Evans; Richard A E Edden
Journal:  Neuroimage       Date:  2012-12-13       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.